162 related articles for article (PubMed ID: 35723873)
21. Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls.
Rögnvaldsson S; Steingrímsson V; Turesson I; Björkholm M; Landgren O; Yngvi Kristinsson S
Haematologica; 2020 Nov; 105(11):2679-2681. PubMed ID: 33131261
[No Abstract] [Full Text] [Related]
22. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
23. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
Goyal G; Rajkumar SV; Lacy MQ; Gertz MA; Buadi FK; Dispenzieri A; Hwa YL; Fonder AL; Hobbs MA; Hayman SR; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kourelis TV; Warsame R; Kyle RA; Kumar SK
Leukemia; 2019 May; 33(5):1273-1277. PubMed ID: 30787429
[TBL] [Abstract][Full Text] [Related]
24. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Eythorsson E; Rognvaldsson S; Thorsteinsdottir S; Einarsson Long T; Reed ER; Sigurdardottir GA; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Olafsson I; Thorsteinsdottir I; Sveinsdottir SV; Sigurdsson F; Thordardottir AR; Palsson R; Indridason OS; Jonsson A; Gislason GK; Olafsson A; Sigurdsson J; Steingrimsdottir H; Hultcrantz M; Durie BGM; Harding S; Landgren O; Aspelund T; Love TJ; Kristinsson SY
Ann Intern Med; 2024 Apr; 177(4):449-457. PubMed ID: 38560901
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
26. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal gammopathy of undetermined significance (MGUS) manifestation in CNS: a regular or chance occurrence?
Prakhova L; Lebedev V; Ilves A; Nazinkina Y
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762271
[TBL] [Abstract][Full Text] [Related]
29. Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.
Lamb MJ; Smith A; Painter D; Kane E; Bagguley T; Newton R; Howell D; Cook G; de Tute R; Rawstron A; Patmore R; Roman E
BMJ Open; 2021 Feb; 11(2):e041296. PubMed ID: 33619185
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
Jordan WE; Emmons R; Vogl D; Morris GJ
Semin Oncol; 2011 Jun; 38(3):327-34. PubMed ID: 21600358
[No Abstract] [Full Text] [Related]
32. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
34. Extensive cutaneous necrosis in monoclonal cryoglobulinemia: an example of monoclonal gammopathy of cutaneous significance.
Lipsker D
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e167. PubMed ID: 30793799
[No Abstract] [Full Text] [Related]
35. Spondylarthritis and monoclonal gammopathy.
Wendling D; Prati C; Berthelot JM; Claudepierre P; Pham T
Joint Bone Spine; 2012 May; 79(3):327-9. PubMed ID: 22459415
[No Abstract] [Full Text] [Related]
36. [Conduct in case of monoclonal gammapathy ?].
Decaux O
Rev Prat; 2018 Sep; 68(7):777-784. PubMed ID: 30869332
[TBL] [Abstract][Full Text] [Related]
37. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B; Castillo JJ; Sarosiek S; Beksac M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D and monoclonal gammopathy of undetermined significance (MGUS) among U.S. Black women.
Ruiz Lopez JN; McNeil GE; Zirpoli G; Palmer JR; Kataria Y; Bertrand KA
Cancer Causes Control; 2024 Feb; 35(2):277-279. PubMed ID: 37707565
[TBL] [Abstract][Full Text] [Related]
39. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
